E2: AF Flashcards
CHA2DS2VASC Score Risk Criteria and their points
C: CHF/Heart failure = 1 point
H: Hypertension = 1 point
A2: Age > or equal to 75 = 2 points!!!
D: Diabetes mellitus = 1 point
S2: Prior stroke or TIA = 2 points!!
V: Vascular disease (MI, PAD, aortic plaque) = 1 point
A: Age 65-74 yr
Sc: Sex (Female) = 1 point
Determine stroke prevention in atrial fibrillation (based on CHA2DS2VASC score)
0 = omit therapy
1 if female = omit therapy
1 if male = consider oral anticoagulant
2 if female = consider oral anticoagulant
> or equal to 2 if male = oral anticoagulant
or equal to 3 if female = oral anticoagulant
When is warfarin preferred over DOAC for stroke prevention in A. Fib? (3)
When is DOAC preferred over warfarin for stroke prevention in A. Fib? (3)
*both mention CrCl
Warfarin > DOAC
1. Valvular AF
2. Renal or hepatic disease
3. Cheap, DOC if patient can’t afford DOAC
DOAC > Warfarin
1. First line for most
2. Can switch if fluctuating INRs from warfarin, SE from warfarin, or lots of short-term warfarin interactions
3. Can use Apixaban in CrCl 15-30 but no CrCl requirement for warfarin
When is one DOAC preferred over others
** MIGHT need to double-check this one
Apixaban preferred if >75 yr (Beer’s list
Goal INR for warfarin in most
Goal INR for warfarin in special population
Normal: 2-3
Special population: AF and CAD who undergo PCI (stent)
Goal: 2-2.5
Goal resting HR for A. Fib
Why
60-80 BPM
Maintain on lower end of normal HR just incase it goes up
Must maintain low HR to prevent ventricular arrythmias and cardiomyopathy
Determine when BBL or CCB is preferred for rate control, especially in relation to comorbid conditions.
Beta-blockers: most effective rate control drug class (AFFIRM trial); preferred over CCBs in HFrEF
CCB: IV diltiazem preferred for hospital rate control; PO CCBs preferred over BBLs in asthma/COPD
Compare and contrast amiodarone and dronedarone
Cost:
DI: Which has more
Elimination: Which is longer
CI
Cost: Dronedarone more expensive
DI: Amiodarone has more DI
Elimination: Amiodarone (14-75 days) vs Dronedarone (13-19 hr)
CI
Both have
-2nd/3rd degree heart bloc
-Bradycardia
-Prolonged QT interval
-Caution in liver disease or severe liver impairment
***Dronedarone also has
-concurrent strong 3A4 inhibitors
-NYHA Class II-IV HF (BBW)
-Permanent AF (BBW)
Compare and contrast amiodarone and dronedarone
SE
Management of SE
Monitoring
Amiodarone:
SE
-Hepatic (BBW)
-Renal
-Arrythmias/torsades de pointes (BBW)
**Phototoxicity (blue-gray skin color)
-Nausea
**Thyroid
**Pulmonary (BBW)
**Ocular
**Polyneuropathy
Management
**Hypothyroidism: levothyroxine
**Hyperthyroidism: antithyroid meds or d/c
**Corneal microdeposits: nothing
**Optic neuritis: d/c
**pulmonary fibrosis: d/c
-Hepatotoxicity: lower dose or d/c if LE >2x ULN
-Bradycardia/heart block: lower dose or d/c
-Neuropathy: lower dose or d/c
Monitoring
-ECG
-Liver enzymes
-Chemistry panel/SCr
-Other proarrythmic drugs
**Thyroid function
**Chest X-ray, PFTs
**Eye exam
Dronedarone: anything listed with the “-“ above plus the following
SE:
_ Renal ↑ SCr by 0.1 mg/dL
_Phototoxicity (rash)
_N/V/D/Abdominal pain
Management:
_Bradycardia/heart block: D/C
Distinguish between AV node and atrial ablation.
AV Node ablation: RATE CONTROL
-Prevents atrial impulses from getting to ventricles
-Creates need for permanent pacemaker and still requires anticoagulation because atria continue to fibrillate
-No mortality benefit, but ↓ hospitalizations and ↑ quality of life
Atrial ablation: RHYTHM CONTROL
-cauterization of cardiac tissue in atria that is responsible for triggering or maintain an arrhythmia (cauterizer areas of atria that are trying to start new and extra beats)